Musk Pay Fight Shows Investor Approval Isn't Universal Cure <https://www.law360.com/capitalmarkets/articles/2275923?nl_pk=abe82add-2a33-4388-8f7e-63d76e8f5534&utm_source=newsletter&utm_medium=email&utm_campaign=capitalmarkets&utm_content=2024-12-20&read_main=1&nlsidx=0&nlaidx=11>
The Delaware Court of Chancery's recent denial of a motion revising its prior rescission of Elon Musk's nearly $56 billion compensation package is a reminder of the heightened standard corporate boards must meet in conflicted controller transactions and that stockholder approval doesn't automatically cure fiduciary wrongdoing, say attorneys at A&O Shearman. Decision attached | Read full article » <https://www.law360.com/capitalmarkets/articles/2275923?nl_pk=abe82add-2a33-4388-8f7e-63d76e8f5534&utm_source=newsletter&utm_medium=email&utm_campaign=capitalmarkets&utm_content=2024-12-20&read_more=1&nlsidx=0&nlaidx=11> | Save to favorites » <https://www.law360.com/capitalmarkets/articles/2275923?nl_pk=abe82add-2a33-4388-8f7e-63d76e8f5534&utm_source=newsletter&utm_medium=email&utm_campaign=capitalmarkets&utm_content=2024-12-20&read_later=1&nlsidx=0&nlaidx=11>
